Studies have shown that marijuana not only helps combat the symptoms of cancer treatment, but also fight the disease. Tetrahydrocannabinol or THC, often credit and fight cancer cells leads, but a new study shows that not only the THC works in this action. The study examined six chemical elements not all hallucinogens found in marijuana called cannabinoids. The study found that each of these chemicals showed effective anticancer properties as THC. Moreover, when these chemicals are used in combination, they have an even greater impact on cancer cells.
The anti-cancer tetrahydrocannabinol (THC), the main component of cannabis and hallucinogenic properties have been recognized for many years, but research into similar derivative compounds of cannabis, known as cannabinoids, have also demonstrated this.
Six cannabinoids studied, each demonstrated as effective anti-cancer properties as those observed in the THC. Importantly, they had a greater effect on cancer cells when combined between them.
This study is a critical step in the unpicking the mysteries of cannabis as a source of medicine. Cannabinoids examined have minimal, if any, side effects hallucinogen and their properties as anti-cancer agents are promising. These agents are capable of interfering with the development of cancer cells, stop in their tracks and prevent them from growing. In some cases, by using specific dosing patterns, they can destroy cancer cells themselves.
Opponents of medical marijuana often claim that the drug is not necessary because there are synthetic drugs like Marinol. However, Marinol contains only THC and none of the other tested for cancer cannabinoids, so it offers only a fraction of the benefits that medical marijuana has to offer.